Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACS: Genetic and Metabolic Determinants in Atrial Fibrillation
NCT02885740Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Mar 2010
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoints: Frequency of genetic polymorphisms related to adenosine and methionine metabolism at Day 0 and Levels of adenosine and methionine cycle nutritional and metabolic determinants at Day 0. Status: unknown.
Beyond the preview
Go deeper on NCT02885740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02885740.